SM
Sabby Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | – | – | 89 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 98 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 92 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 83 |
|
|
2022
Q1 | – | Sell |
-940,400
| Closed | -$4.7M | – | 100 |
|
|
2021
Q4 | $4.7M | Buy |
+940,400
| New | +$4.7M | 0.68% | 7 |
|
|
2019
Q1 | – | Sell |
-138,958
| Closed | -$6.39M | – | 68 |
|
|
2018
Q4 | $6.39M | Buy |
138,958
+38,589
| +38% | +$1.78M | 1.41% | 3 |
|
|
2018
Q3 | $4.45M | Sell |
100,369
-48,335
| -33% | -$2.14M | 0.57% | 7 |
|
|
2018
Q2 | $5.83M | Buy |
148,704
+129,881
| +690% | +$5.09M | 0.9% | 7 |
|
|
2018
Q1 | $1.36M | Sell |
18,823
-123,362
| -87% | -$8.92M | 0.16% | 18 |
|
|
2017
Q4 | $9.36M | Buy |
142,185
+58,828
| +71% | +$3.87M | 0.85% | 3 |
|
|
2017
Q3 | $4.18M | Buy |
+83,357
| New | +$4.18M | 0.27% | 3 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 132 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 148 |
|
|
2016
Q1 | – | Sell |
-19,000
| Closed | -$423K | – | 180 |
|
|
2015
Q4 | $423K | Sell |
19,000
-4,990
| -21% | -$111K | 0.02% | 116 |
|
|
2015
Q3 | $566K | Buy |
+23,990
| New | +$566K | 0.02% | 141 |
|
|
2015
Q2 | – | Sell |
-5,000
| Closed | -$463K | – | 167 |
|
|
2015
Q1 | $463K | Buy |
+5,000
| New | +$463K | 0.02% | 101 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 123 |
|